Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

A Forward Look, The Year Ahead - Research Report on WellPoint, Inc., E I Du Pont De Nemours And Co., The Dow Chemical Company, Dover Corp and Rexnord Corp

DOV, DD, ELV, ZWS
A Forward Look, The Year Ahead - Research Report on WellPoint, Inc., E I Du Pont De Nemours And Co., The Dow Chemical Company, Dover Corp and Rexnord Corp

NEW YORK, March 14, 2013 /PRNewswire/ --

Today, Investors Alliance announced new research reports highlighting WellPoint, Inc. (NYSE:WLP), E I Du Pont De Nemours And Co. (NYSE:DD), The Dow Chemical Company (NYSE:DOW), Dover Corp (NYSE:DOV) and Rexnord Corp (NYSE:RXN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

WellPoint, Inc. Research Report

Wellpoint logged revenue of $15.27 billion in its latest earnings report, enough to meet the expectations of S&P Capital IQ. Earnings per share came in at $1.03, while gross, operating, and net margins increased 20.4 percent, 4.1 percent, and 3 percent, respectively. The company is fresh from its selection of new CEO Joseph Swedish, who will start on March 25. The former President of Trinity Health will succeed Angela Braly, who resigned last year after posting subpar results. The new CEO helped grow Trinity's revenues by 50 percent in seven years, while doubling operating profit margins. The Street puts Wellpoint as a "buy," citing the performance of its net income, revenue growth, financial position with reasonable debt levels, valuation levels and cash flow from operations. The Full Research Report on WellPoint, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.Investors-Alliance.com/r/full_research_report/dcf6_WLP]

--

E I Du Pont De Nemours And Co. Research Report

Du Pont, which also has operations in agriculture, electronics, among others aside from chemicals, has been upgraded to a "neutral" by Zacks after posting better-than-expected results in Q4 2012 with net sales of $7.3 billion compared to the estimated $7.25 billion, though is flat year-over-year. However, good cash flow from operations and notable return on equity should outweigh the underperforming net income numbers. Du Pont is the world's largest manufacturer of titanium dioxide, a white pigment used in paint. The product should help the company's performance chemicals unit stable throughout Q1 as excess inventories are used up and demand dries up. However, Du Pont's other chemical units are slowly being sold off to other companies. The company is on the verge of selling its cyanide business, which could fetch as much as $700 million and is projected to have net earnings of around $100 million. This is part of the company's transition to a more food and agriculture-based business, with an earlier sale of its car paint unit to the Carlyle Group in mid-2012.. The Full Research Report on E I Du Pont De Nemours And Co. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.Investors-Alliance.com/r/full_research_report/0bb1_DD]

--

The Dow Chemical Company Research Report

Dow Chemical is expected to receive a whopping 32% jump in its earnings numbers despite posting dismal numbers in Q3 and spending a lot for restructuring programs to cut costs. The stock went up as much as 13 percent, as Motley Fool reported. The positive gains can be credited to its decision to restart operations of its ethylene cracker in Louisiana, which has been idle for four years. Coincidentally, ethylene raw material ethane has hit a five-year low around the same time the plant reopened. However, a Motley Fool report says it won't make a dent on Dow's earnings numbers. However, the restructuring plan is expected to save Dow an estimated $500 million as it cuts close to 2,400 jobs and 20 plants. It would also be posting a restructuring charge of up to $1.1 billion during the last quarter.. The Full Research Report on The Dow Chemical Company - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.Investors-Alliance.com/r/full_research_report/1006_DOW]

--

Dover Corp Research Report

Dover, who has businesses in telecoms, energy, engineered systems, and printing and identification, beat expectations with its adjusted earnings per share for Q4 at $1.09 per share, compared to Zacks' estimate of $1.07. Revenues meanwhile came in at $2 billion for that quarter, or more than 6 percent year over year, which met expectations. The stock had been hit recently due to concerns over its handset business, though some analysts say it might have been overdone considering Dover's ability to generate cash and its growth record. The issue lies with underwhelming sales of its major customer Nokia, who is being supplied with products from its Sound Solutions business. Motley Fool says Dover does sell to Samsung as well, who is now the largest smartphone manufacturer worldwide. The only company it does not have a decent market share with is Apple, who itself has been slowly declining as of late. In addition, the relatively weak Q4 numbers reflect normal seasonality. The Street rates Dover as a "buy," citing its performance in revenue growth, debt, stock price, cash flow from operations, and earnings per share. The Full Research Dover Corp - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.Investors-Alliance.com/r/full_research_report/aa96_DOV]

--

Rexnord Corp Research Report

Rexnord saw its shares increase 14, after news of a potential sale surfaced after initiating a "review of strategic alternatives" with Goldman Sachs serving as its financial adviser. The sale of one or both its business platforms are also being considered. Its Q3 results indicated net income of $9.2 million or 9 cents per share, up from $5.6 million or $0.08 per share year over year. Income from continuing operations for the third quarter was $11.4 million or $0.11 per share, compared to $5.5 million or $0.08 per share the same time the previous year. For Q4, the company forecast sales to be between $535 million to $555 million, while analysts currently expect the company to post revenue of $555.25 million. The Full Research Report on Rexnord Corp - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.Investors-Alliance.com/r/full_research_report/fe8f_RXN]

--

Consider Investors Alliance

Tired of hearing about the latest, greatest trade opportunity... only to realize that the ship has long sailed? You need a strong, informative community in your arsenal. Join the group that has been consistently identifying momentous situations as they develop - long before they become the next top news on major financial networks.

Contact: Patricia Byers
Email: press@Investors-Alliance.com
Main: +1-480-745-7826


SOURCE Investors-Alliance



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today